Shares of Genus plc (LON:GNS) have received a consensus rating of “Hold” from the six brokerages that are presently covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 2,217 ($29.84).
A number of analysts recently commented on GNS shares. N+1 Singer upgraded shares of Genus to a “buy” rating and upped their price objective for the company from GBX 1,844 ($24.82) to GBX 2,485 ($33.45) in a research report on Monday, October 30th. Peel Hunt restated a “buy” rating and issued a GBX 2,600 ($34.99) price objective on shares of Genus in a research report on Monday, September 4th. Kepler Capital Markets started coverage on shares of Genus in a research report on Tuesday, November 7th. They issued a “hold” rating and a GBX 2,353 ($31.67) price objective for the company. Liberum Capital restated a “hold” rating and issued a GBX 2,100 ($28.26) price objective on shares of Genus in a research report on Monday, October 30th. Finally, Numis Securities restated a “hold” rating and issued a GBX 1,815 ($24.43) price objective on shares of Genus in a research report on Thursday, September 7th.
Genus (GNS) traded down GBX 0.99 ($0.01) during mid-day trading on Thursday, reaching GBX 2,340 ($31.49). 19,500 shares of the company’s stock were exchanged, compared to its average volume of 60,071. Genus has a fifty-two week low of GBX 1,652 ($22.23) and a fifty-two week high of GBX 2,500 ($33.65).
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with MarketBeat.com's FREE daily email newsletter.